Abidi1, A. H., Alghamdi, S. S., & Derefinko, K. (2022). A critical review of cannabis in medicine and dentistry: A look back and the path forward. Clinical and Experimental Dental Research, 8(3):613-631. https://doi.org/10.1002/cre2.564

Arkell, T. R., Lintzeris, N., Kevin, R. C., Ramaekers, J. G., Vandrey, R., Irwin, C., Haber, P. S., & McGregor, I. S. (2019). Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Psychopharmacology, Volume 236, pages 2713-2724. https://doi.org/10.1007/s00213-019-05246-8

Arkell, T. R., Manning, B., Downey, L. A., & Hayley, A. C. (2023). A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance. CNS Drugs, Volume 37, pages 981-992. https://doi.org/10.1007/s40263-023-01046-z

Azizoddin, D. R., Cohn, A. M., Ulahannan, S. V., Henson, C. E., Alexander, A. C., Moore, K. N., Holman, L. L., Boozary, L. K., Sifat, M. S., & Kendzor, D. E. (2024). Cannabis use among adults undergoing cancer treatment. Cancer, 129(21):3498-3508. https://doi.org/10.1002/cncr.34922

Babalonis, S., Raup-Konsavage, W. M., Akpunonu, P. D., Balla, A., & Vrana, K. E. (2021). D8-THC: Legal Status, Widespread Availability, and Safety Concerns. Cannabis and Cannabinoid Research, 6(5):362-365. doi: 10.1089/can.2021.0097

Bar-Sela, G., Zalman, D., Semenysty, V., & Ballan, E. (2019). The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study. Integrative Cancer Therapies. https://doi.org/10.1177/1534735419881498

Baron, E. P., Lucas, P., Eades, J., & Hogue, O. (2018). Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. The Journal of Headache and Pain, Volume 19, article number 37. https://doi.org/10.1186/s10194-018-0862-2

Barrus, D. G., Capogrossi, K. L., Cates, S. C., Gourdet, C. K., Peiper, N. C., Novak, S. P., Lefever, T. W., & Wiley, J. L. (2016). Tasty THC: Promises and Challenges of Cannabis Edibles. Methods Rep RTI Press. https://doi.org/10.3768/rtipress.2016.op.0035.1611

Behzad, D., Patel, S., Besa, R., Chan, A. W., Chen, S., Rueda, S., Ruocco, A. C., & Ciano, P. D. (2025). Effects of different methods of cannabis use on cognition and blood THC: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Volume 139, 20 June 2025, 111399. https://doi.org/10.1016/j.pnpbp.2025.111399

Berl, V., Hurd, Y. L., Lipshutz, B. H., Roggen, M., Mathur, E. J., & Evans, M. (2022). A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History. Cannabis and Cannabinoid Research, 7(6):777-789. https://doi.org/10.1089/can.2021.0176

Berman, P., Futoran, K., Lewitus, G. M., Mukha, D., Benami, M., Shlomi, T., & Meiri, D. (2018). A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis. Scientific Reports volume 8, Article number: 14280. https://doi.org/10.1038/s41598-018-32651-4

Bhardwaj, A. K., Allsop, D. J., Copeland, J., McGregor, I. S., Dunlop, A., Shanahan, M., Bruno, R., Phung, N., Montebello, M., Sadler, C., Gugusheff, J., Jackson, M., Luksza, J., Lintzeris, N., & group, A. R. F. C. D. (. S. (2018). Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol. BMC Psychiatry, Volume 18, article number 140. https://doi.org/10.1186/s12888-018-1682-2

Bidwell, L. C., Karoly, H. C., Torres, M. O., Master, A., Bryan, A. D., & Hutchison, K. E. (2022). A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. Psychopharmacology (Berl), 239(2):385-397. https://doi.org/10.1007/s00213-021-06007-2

Bilbao, A. & Spanagel, R. (2022). Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Medicine, Volume 20, article number 259. https://doi.org/10.1186/s12916-022-02459-1

Bloomfield, M. A., Hindocha, C., Green, S. F., Wall, M. B., Lees, R., Petrilli, K., Costello, H., Ogunbiyi, M. O., Bossong, M. G., & Freeman, T. P. (2019). The neuropsychopharmacology of cannabis: A review of human imaging studies. Pharmacology & Therapeutics, Volume 195, March 2019, Pages 132-161. https://doi.org/10.1016/j.pharmthera.2018.10.006

Borgan, F., Beck, K., Butler, E., McCutcheon, R., Veronese, M., Vernon, A., & Howes, O. D. (2019). The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species. Psychopharmacology, Volume 236, pages 3257-3270. https://doi.org/10.1007/s00213-019-05283-3

Burr, J. F., Cheung, C. P., Kasper, A. M., Gillham, S. H., & Close, G. L. (2021). Cannabis and Athletic Performance. Sports Medicine, Volume 51, pages 75-87. https://doi.org/10.1007/s40279-021-01505-x

Cavalheiro, E. K. F. F., Costa, A. B., Salla, D. H., Silva, M. R. D., Mendes, T. F., Silva, L. E. D., Turatti, C. D. R., Bitencourt, R. M. D., & Rezin, G. T. (2022). Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target. Cannabis and Cannabinoid Research, 7(2):135-151. https://doi.org/10.1089/can.2021.0016

Chacon, F. T., Raup-Konsavage, W. M., Vrana, K. E., & Kellogg, J. J. (2022). Secondary Terpenes in Cannabis sativa L.: Synthesis and Synergy. Biomedicines, 10(12), 3142. https://doi.org/10.3390/biomedicines10123142

Chandni Hindochaa, N., Freemana, T. P., Schafera, G., Gardenera, C., Dasa, R. K., Celia J.A. Morgana, B., & Currana, H. V. (2015). Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users. European Neuropsychopharmacology, Volume 25, Issue 3, March 2015, Pages 325-334. https://doi.org/10.1016/j.euroneuro.2014.11.014

Christensen, C., Rose, M., Cornett, C., & Alles, M. (2023). Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn't. Biomedicines, 11(8), 2323. https://doi.org/10.3390/biomedicines11082323

Connor, J. P., Stjepanovic, D., Budney, A. J., Foll, B. L., & Hall, W. D. (2021). Clinical management of cannabis withdrawal. Addiction, 117(7):2075-2095. https://doi.org/10.1111/add.15743

Cooper, Z. D., Bedi, G., Ramesh, D., Balter, R., Comer, S. D., & Haney, M. (2018). Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology volume 43, pages 2046-2055. https://doi.org/10.1038/s41386-018-0011-2

Cooray, R., Gupta, V., & Suphioglu, C. (2020). Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review. Molecular Neurobiology, Volume 57, pages 4878-4890. https://doi.org/10.1007/s12035-020-02054-6

Crowley, K., Vries, S. T. D., & Moreno-Sanz, G. (2018). Self-Reported Effectiveness and Safety of Trokie(R) Lozenges: A Standardized Formulation for the Buccal Delivery of Cannabis Extracts. Frontiers in Neuroscience, Volume 12. https://doi.org/10.3389/fnins.2018.00564

Docter, S., Khan, M., Gohal, C., Ravi, B., Bhandari, M., Gandhi, R., & Leroux, T. (2020). Cannabis Use and Sport: A Systematic Review. Sports Health: A Multidisciplinary Approach, volume 12, issue 2. https://doi.org/10.1177/1941738120901670

Dryburgh, L. M., Bolan, N. S., Grof, C. P., Galettis, P., Schneider, J., Lucas, C. J., & Martin, J. H. (2018). Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. Br J Clin Pharmacol, 84(11):2468-2476. https://doi.org/10.1111/bcp.13695

Englund, A., Oliver, D., Chesney, E., Chester, L., Wilson, J., Sovi, S., Micheli, A. D., Hodsoll, J., Fusar-Poli, P., Strang, J., Murray, R. M., Freeman, T. P., & McGuire, P. (2023). Does cannabidiol make cannabis safer? A randomised, double- blind, cross-over trial of cannabis with four different CBD:THCratios. Neuropsychopharmacology volume 48, pages 869-876. https://doi.org/10.1038/s41386-022-01478-z

Ewell, T. R., Bomar, M. C., Abbotts, K. S. S., Butterklee, H. M., Dooley, G. P., & Bell, C. (2022). Edible marijuana and cycle ergometer exercise. Frontiers in Physiology, volume 13. https://doi.org/10.3389/fphys.2022.1085822

Farokhnia, M., McDiarmid, G. R., Newmeyer, M. N., Munjal, V., Abulseoud, O. A., Huestis, M. A., & Leggio, L. (2020). Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. Translational Psychiatry volume 10, Article number: 71. https://doi.org/10.1038/s41398-020-0756-3

Fedorova, E. V., Wong, C. F., Ataiants, J., Iversonb, E., Conn, B., & Lankenaua, S. E. (2021). Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles. Drug and Alcohol Dependence, 221:108648. https://doi.org/10.1016/j.drugalcdep.2021.108648

Ferber, S. G., Namdar, D., Hen-Shoval, D., Eger, G., Koltai, H., Shoval, G., Shbiro, L., & Weller, A. (2020). The Entourage Effect: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. Current Neuropharmacology, 18(2):87-96. https://doi.org/10.2174/1570159X17666190903103923

Franco, G. D. R. R., Smid, S., & Jr., C. V. (2021). Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases. Current Neuropharmacology, 19(4):449-464. https://doi.org/10.2174/1570159X18666200720172624

Freeman, T. P., Beeching, E., Craft, S., Forti, M. D., Frison, G., Lindholst, C., Oomen, P. E., Potter, D., Rigter, S., Thomsen, K. R. M., Zamengo, L., Cunningham, A., Groshkova, T., & Sedefov, R. (2025). Applying machine learning to international drug monitoring: classifying cannabis resin collected in Europe using cannabinoid concentrations. European Archives of Psychiatry and Clinical Neuroscience, Volume 275, pages 421-429. https://doi.org/10.1007/s00406-024-01816-w

Froude, A. M., Pangborn, N., Britz-McKibbin, P., MacKillop, J., & Balodis, I. (2024). Potential Risks from Cannabis-Infused Beverages: A Critical Review. Cannabis, 7(3):134-166. https://doi.org/10.26828/cannabis/2024/000271

Gertsch, J., Pertwee, R. G., & Marzo, V. D. (2010). Phytocannabinoids beyond the Cannabis plant-do they exist?. Br J Pharmacol, 160(3):523-9. https://doi.org/10.1111/j.1476-5381.2010.00745.x

Gibson, L. P., Mueller, R. L., Winiger, E. A., Klawitter, J., Sempio, C., Williams, S., Bryan, A. D., Bidwell, L. C., & Hutchison, K. E. (2024). Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products. Cannabis and Cannabinoid Research, Vol. 9, No. 1. https://doi.org/10.1089/can.2022.0020

Goodpaster, K. P. S. (2025). Cannabis, Weight, and Weight-Related Behaviors. Current Obesity Reports, Volume 14, article number 40. https://doi.org/10.1007/s13679-025-00633-z

Goulette, M., Schlienz, N. J., Case, A. A., Hansen, E., Rivard, C., Ashare, R. L., Goniewicz, M. L., Bansal-Travers, M., Hyland, A., & Smith, D. M. (2024). Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors. Supportive Care in Cancer, Volume 32, article number 210. https://doi.org/10.1007/s00520-024-08374-w

Grof, C. P. L. (2018). Cannabis, from plant to pill. Br J Clin Pharmacol, 84(11):2463-2467. https://doi.org/10.1111/bcp.13618

Grotenhermen, F., Russo, E., & Zuardi, A. W. (2017). Even High Doses of Oral Cannabidiol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. Cannabis and Cannabinoid. Cannabis and Cannabinoid Research, 1(1):102-112. https://doi.org/10.1089/can.2016.0036

Gunasekera, B., Diederen, K., & Bhattacharyya, S. (2021). Cannabinoids, reward processing, and psychosis. Psychopharmacology, Volume 239, pages 1157-1177. https://doi.org/10.1007/s00213-021-05801-2

Gurgenci, T., Hardy, J., Huggett, G., Foster, K., Pelecanos, A., Greer, R., Philip, J., Haywood, A., Mendis, R., Yates, P., & Good, P. (2024). Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. Trials, Volume 25, article number 293. https://doi.org/10.1186/s13063-024-08091-z

Haidar, Z., Traboulsi, H., Eidelman, D. H., & Baglole, C. J. (2023). Differential inflammatory profile in the lungs of mice exposed to cannabis smoke with varying THC:CBD ratio. Organ Toxicity and Mechanisms, Volume 97, pages 1963-1978. https://doi.org/10.1007/s00204-023-03514-3

Hall, D., Lawn, W., Ofori, S., Trinci, K., Borissova, A., Mokrysz, C., Petrilli, K., Bloomfield, M. A. P., Wall, M. B., Freeman, T. P., & Curran, H. V. (2024). The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study. Psychopharmacology, Volume 241, pages 1125-1134. https://doi.org/10.1007/s00213-024-06543-7

Hardy, J., Haywood, A., Gogna, G., Martin, J., Yates, P., Greer, R., & Good, P. (2020). Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double- blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD). Trials, Volume 21, article number 611. https://doi.org/10.1186/s13063-020-04541-6

Harris, H. M., Rousseau, M. A., Wanas, A. S., Radwan, M. M., Caldwell, S., Sufka, K. J., & ElSohly, M. A. (2019). Role of Cannabinoids and Terpenes in Cannabis-Mediated Analgesia in Rats. Cannabis and Cannabinoid Research, Vol. 4, No. 3. https://doi.org/10.1089/can.2018.0054

Hashiesh, H. M., Sharma, C., Goyal, S. N., Sadek, B., Jha, N. K., Kaabi, J. A., & Ojha, S. (2021). A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomedicine & Pharmacotherapy, Volume 140, August 2021, 111639. https://doi.org/10.1016/j.biopha.2021.111639

Henson, J. D., Vitetta, L., & Hall, S. (2022). Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions. Inflammopharmacology, Volume 30, pages 1167-1178. https://doi.org/10.1007/s10787-022-01020-z

Hermush, V., Mizrahi, N., Brodezky, T., & Ezra, R. (2025). Enhancing cannabinoid bioavailability: a crossover study comparing a novel self-nanoemulsifying drug delivery system and a commercial oil-based formulation. Journal of Cannabis Research, Volume 7, article number 35. https://doi.org/10.1186/s42238-025-00294-8

Hindocha, C., Lawn, W., Freeman, T. P., & Curran, H. V. (2017). Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users. Psychopharmacology (Berl), 2017 Nov;234(21):3153-3163. https://doi.org/10.1007/s00213-017-4698-2

Hoch, E., Niemann, D., Keller, R. V., Schneider, M., Friemel, C. M., Preuss, U. W., Hasan, A., & Pogarell, O. (2019). How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. European Archives of Psychiatry and Clinical Neuroscience, Volume 269, pages 87-105. https://doi.org/10.1007/s00406-019-00984-4

Hoch, E., Volkow, N. D., Friemel, C. M., Lorenzetti, V., Freeman, T. P., & Hall, W. (2025). Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits. European Archives of Psychiatry and Clinical Neuroscience, Volume 275, pages 281-292. https://doi.org/10.1007/s00406-024-01880-2

Holdman, R., Vigil, D., Robinson, K., Shah, P., & Contreras, A. E. (2022). Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications. Cannabis and Cannabinoid Research, 7(4):451-463. https://doi.org/10.1089/can.2020.0154

Hutten, N. R. P. W., Arkell, T. R., Vinckenbosch, F., Schepers, J., Kevin, R. C., Theunissen, E. L., Kuypers, K. P. C., McGregor, I. S., & Ramaekers, J. G. (2022). Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis. Psychopharmacology, Volume 239, pages 3731-3741. https://doi.org/10.1007/s00213-022-06248-9

Jin, D., Dai, K., Xie, Z., & Chen, J. (2020). Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes. Scientific Reports volume 10, Article number: 3309. https://doi.org/10.1038/s41598-020-60172-6

Kaczor, E. E., Greene, K., Babu, K. M., Berthold, E. C., Sharma, A., & Carreiro, S. P. (2023). Commercial Delta-8 THC Products: an Analysis of Content and Labeling. Journal of Medical Toxicology, Volume 20, pages 31-38. https://doi.org/10.1007/s13181-023-00974-y

Kalaba, M., MacNair, L., Peters, E. N., Eglit, G. M., Rapin, L., Hage, C. E., Prosk, E., & Ware, M. A. (2021). Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec. Cannabis and Cannabinoid Research, 6(6):564-572. https://doi.org/10.1089/can.2020.0140

Karschner, E., Darwin, W., RP McMahon, F. L., Wright, S., Goodwin, R., & Huestis, M. (2013). Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration. Clinical Pharmacology & Therapeutics, Volume 89, Issue3. https://doi.org/10.1038/clpt.2010.318

Karst, M. (2024). Overview: Chronic Pain and Cannabis-Based Medicines. Pharmacopsychiatry, 2024 May, 57(3):152-159. https://doi.org/10.1055/a-2231-6630

Kearney-Ramos, T., Herrmann, E. S., Belluomo, I., Matias, I., Vallee, M., Monlezun, S., Piazza, P. V., & Haney, M. (2023). The Relationship Between Circulating Endogenous Cannabinoids and the Effects of Smoked Cannabis. Cannabis and Cannabinoid Research, Volume 8, Issue 6. https://doi.org/10.1089/can.2021.0185

Khalsa, J. H., Bunt, G., Blum, K., Maggirwar, S. B., Galanter, M., & Potenza, M. N. (2022). Review: Cannabinoids as Medicinals. Current Addiction Reports, Volume 9, pages 630-646. https://doi.org/10.1007/s40429-022-00438-3

Kitdumrongthum, S. & Trachootham, D. (2023). An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products. Molecules, 28(6), 2791. https://doi.org/10.3390/molecules28062791

Korb, L., Tromans, S., Perera, B., Khan, N., Burrows, L., Laugharne, R., Hassiotis, A., Allgar, V., Efron, D., Maidment, I., & Shankar, R. (2023). The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review. Journal of Psychopharmacology, volume 37, issue 12. https://doi.org/10.1177/02698811231209192

Laux, D. A., Azuma, M. C., & Cain, M. E. (2025). Effects of repeated voluntary oral consumption of synthetic delta-9-tetrahydrocannabinol on locomotor activity and cannabinoid receptor 1 expression. Behavioural Brain Research, Volume 477, 4 February 2025, 115315. https://doi.org/10.1016/j.bbr.2024.115315

LaVigne, J. E., Hecksel, R., Keresztes, A., & Streicher, J. M. (2021). Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific Reports volume 11, Article number: 8232. https://doi.org/10.1038/s41598-021-87740-8

Lawn, W., Freeman, T. P., Pope, R. A., Joye, A., Harvey, L., Hindocha, C., Mokrysz, C., Moss, A., Wall, M. B., Bloomfield, M. A., Das, R. K., Morgan, C. J., Nutt, D. J., & Curran, H. V. (2016). Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. Psychopharmacology (Berl), 233(19-20):3537-52. https://doi.org/10.1007/s00213-016-4383-x

Leinen, Z. J., Mohan, R., Premadasa, L. S., Acharya, A., Mohan, M., & Byrareddy, S. N. (2023). Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications. Biomedicines, 11(10), 2630. https://doi.org/10.3390/biomedicines11102630

Lins, B. R., Anyaegbu, C. C., Hellewell, S. C., Papini, M., McGonigle, T., Prato, L. D., Shales, M., & Fitzgerald, M. (2023). Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds. Journal of Neuroinflammation, Volume 20, article number 77. https://doi.org/10.1186/s12974-023-02734-9

Lintzeris, N., Mills, L., Abelev, S. V., Suraev, A., Arnold, J. C., & McGregor, I. S. (2022). Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20). Harm Reduction Journal, Volume 19, article number 88. https://doi.org/10.1186/s12954-022-00666-w

Lord, S., Hardy, J., & Good, P. (2022). Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?. Curr Treat Options Oncol, 2022 Apr;23(4):514-525. https://doi.org/10.1007/s11864-021-00934-0

MacDonald-Spracklina, R., DeWolfb, D., & Thompsona, K. (2025). Mode Matters: Investigating the Associations Between Mode of Cannabis Use and Self-Reported Physical and Psychological Effects. Substance Use & Misuse, Volume 60, Issue 14, pages 2244-2253.. https://doi.org/10.1080/10826084.2025.2538733

Madras, B. K. (2019). Tinkering with THC-to-CBD ratios in Marijuana. Neuropsychopharmacology volume 44, pages 215-216. https://doi.org/10.1038/s41386-018-0217-3

Manning, B., Downey, L. A., Narayan, A., & Hayley, A. C. (2023). A systematic review of oculomotor deficits associated with acute and chronic cannabis use. Addiction Biology, Volume 29, Issue 1. https://doi.org/10.1111/adb.13359

Mavedatnia, D., Levin, M., Lee, J. W., Hamour, A. F., Dizon, K., & Le, T. (2023). Cannabis use amongst tinnitus patients: consumption patterns and attitudes. Journal of Otolaryngology - Head & Neck Surgery, 52(1). https://doi.org/10.1186/s40463-022-00603-8

McCartney, D., Suraev, A. S., Doohan, P. T., Irwin, C., Kevin, R. C., Grunstein, R. R., Hoyos, C. M., & McGregor, I. S. (2022). Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial. Journal of Psychopharmacology, volume 36, issue 12. https://doi.org/10.1177/02698811221095356

McCartney, D., Suraev, A., & McGregor, I. S. (2023). The Next Day Effects of Cannabis Use: A Systematic Review. Cannabis and Cannabinoid Research, 8(1):92-114. https://doi.org/10.1089/can.2022.0185

McClements, D. J. (2020). Annual Review of Food Science and Technology Enhancing Efficacy, Performance, and Reliability of 16:45:11 Cannabis Edibles: Insights from Lipid Bioavailability Studies. Annual Review of Food Science and Technology Volume 11. https://doi.org/10.1146/annurev-food-032519-051834

McDew-White, M., Lee, E., Premadasa, L. S., Alvarez, X., Okeoma, C. M., & Mohan, M. (2023). Cannabinoids modulate the microbiota-gut-brain axis in HIV/SIV infection by reducing neuroinflammation and dysbiosis while concurrently elevating endocannabinoid and indole-3-propionate levels. Journal of Neuroinflammation, Volume 20, article number 62. https://doi.org/10.1186/s12974-023-02729-6

McDonald, A. C., Haaz, I. G., Qi, W., Crowley, D. C., Guthrie, N., Evans, M., & Bosnyak, D. (2021). Sensitivity, Specificity and Accuracy of a Novel EEG-Based Objective Test, the Cognalyzer , in Detecting Cannabis Psychoactive Effects. Advances in Therapy, Volume 38, pages 2513-2531. https://doi.org/10.1007/s12325-021-01718-6

Meyer, T., Funke, A., Münch, C., Kettemann, D., Maier, A., Walter, B., Thomas, A., & Spittel, S. (2019). Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD). BMC Neurology, Volume 19, article number 222. https://doi.org/10.1186/s12883-019-1443-y

Müller-Vahl, K. R. (2024). Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature. Pharmacopsychiatry, 2024 May;57(3):104-114. https://doi.org/10.1055/a-2256-0098

Nahler, G. (2022). Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics. Pharmaceutical Medicine, Volume 36, pages 99-129. https://doi.org/10.1007/s40290-022-00420-4

Newmeyera, M. N., Swortwooda, M. J., Abulseouda, O. A., & Huestisa, M. A. (2017). Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration. Drug and Alcohol Dependence, Volume 175, 1 June 2017, Pages 67-76. https://doi.org/10.1016/j.drugalcdep.2017.02.003

Oultram, J. M. J., Pegler, J. L., Bowser, T. A., Ney, L. J., Eamens, A. L., & Grof, C. P. L. (2021). Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC. Biomedicines2021, 9(3), 234. https://doi.org/10.3390/biomedicines9030234

Peralt, A., Ke, P., & Castaneto, M. S. (2022). Impact of cannabis- infused edibles on public safety and regulation. Journal of Forensic Sciences, Volume 67, Issue6. https://doi.org/10.1111/1556-4029.15135

Peters, E. N., MacNair, L., Mosesova, I., Christians, U., Sempio, C., Klawitter, J., Land, M. H., Ware, M. A., Turcotte, C., & Bonn-Miller, M. O. (2022). Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and delta-9-tetrahydrocannabinol: a pilot study. European Journal of Clinical Pharmacology, Volume 78, pages 259-265. https://doi.org/10.1007/s00228-021-03232-8

Petzke, F., Tölle, T., Fitzcharles, M., & Häuser, W. (2021). Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain. CNS Drugs, Volume 36, pages 31-44. https://doi.org/10.1007/s40263-021-00879-w

Poyatos, L., Pérez-Acevedo, A. P., Papaseit, E., Pérez-Mañá, C., Martin, S., Hladun, O., Siles, A., Torrens, M., Busardo, F. P., & Farré, M. (2020). Oral Administration of Cannabis and delta-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review. Medicina (Kaunas), 56(6):309. https://doi.org/10.3390/medicina56060309

Preteroti, M., Wilson, E. T., Eidelman, D. H., & Baglole, C. J. (2023). Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease. Respiratory Research, Volume 24, article number 95. https://doi.org/10.1186/s12931-023-02399-1

Pérez-Valenzuela, E., Hudson, R., Uzuneser, T., Felice, M. D., Szkudlarek, H., Rushlow, W., & Laviolette, S. R. (2024). Sex-Dependent Synergism of an Edible THC: CBD Formulation in Reducing Anxiety and Depressive-like Symptoms Following Chronic Stress. Current Neuropharmacology, 22(12):2059-2078. https://doi.org/10.2174/1570159X21666230912101441

Raghunathan, N. J., Brens, J., Vemuri, S., Li, Q. S., Mao, J. J., & Korenstein, D. (2022). In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center. Supportive Care in Cancer, Volume 30, pages 7491-7497. https://doi.org/10.1007/s00520-022-07170-8

Ramaekers, J. G., Mason, N. L., Toennes, S. W., Theunissen, E. L., & Amico, E. (2022). Functional brain connectomes reflect acute and chronic cannabis use. Scientific Reports volume 12, Article number: 2449. https://doi.org/10.1038/s41598-022-06509-9

Raymundi, A. M., Silva, T. R. D., Sohn, J. M. B., Bertoglio, L. J., & Stern, C. A. (2020). Effects of delta-9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies. BMC Psychiatry, Volume 20, article number 420. https://doi.org/10.1186/s12888-020-02813-8

Reisdorph, N., Doenges, K., Levens, C., Manke, J., Armstrong, M., Smith, H., Quinn, K., Radcliffe, R., Reisdorph, R., Saba, L., & Kuhn, K. A. (2024). Oral Cannabis consumption and intraperitoneal THC:CBD dosing results in changes in brain and plasma neurochemicals and endocannabinoids in mice. Journal of Cannabis Research, Volume 6, article number 10. https://doi.org/10.1186/s42238-024-00219-x

Ruiz, C. M., Torrens, A., Castillo, E., Perrone, C. R., Cevallos, J., Inshishian, V. C., Harder, E. V., Justeson, D. N., Huestis, M. A., Swarup, V., Piomelli, D., & Mahler, S. V. (2021). Pharmacokinetic, behavioral, and brain activity effects of delta-9-tetrahydrocannabinol in adolescent male and female rats. Neuropsychopharmacology volume 46, pages 959-969. https://doi.org/10.1038/s41386-020-00839-w

Sallam, N. A., Peterson, C. S., Baglot, S. L., Kohro, Y., Trang, T., Hill, M. N., & Borgland, S. L. (2023). Sex Differences in Plasma, Adipose Tissue, and Central Accumulation of Cannabinoids, and Behavioral Effects of Oral Cannabis Consumption in Male and Female C57BL/6 Mice. International Journal of Neuropsychopharmacology, Volume 26, Issue 11, Pages 773-783. https://doi.org/10.1093/ijnp/pyad055

Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020). Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. BMC Psychiatry, Volume 20, article number 24. https://doi.org/10.1186/s12888-019-2409-8

Schlienz, N. J., Spindle, T. R., Cone, E. J., Herrmann, E. S., Bigelow, G. E., Mitchell, J. M., Flegeld, R., LoDico, C., & Vandrey, R. (2020). Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis. Drug and Alcohol Dependence, 211:107969. https://doi.org/10.1016/j.drugalcdep.2020.107969

Sharpe, L., Sinclair, J., Kramer, A., Manincor, M. D., & Sarris, J. (2020). Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of Translational Medicine, Volume 18, article number 374. https://doi.org/10.1186/s12967-020-02518-2

Silva-Reis, R., Silva, A. M. S., Oliveira, P. A., & Cardoso, S. M. (2023). Antitumor Effects of Cannabis sativa Bioactive Compounds on Colorectal Carcinogenesis. Biomolecules, 13(5), 764. https://doi.org/10.3390/biom13050764

Sinclair, J., Collett, L., Abbott, J., Pate, D. W., Sarris, J., & Armour, M. (2021). Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms. PLOS One. https://doi.org/10.1371/journal.pone.0258940

Sionov, R. V. & Steinberg, D. (2022). Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles. Biomedicines, 10(3), 631. https://doi.org/10.3390/biomedicines10030631

Smokera, M. P., Mackieb, K., Lapisha, C. C., & Boehm, S. L. (2019). Self-Administration of Edible Delta-9-Tetrahydrocannabinol and Associated Behavioral Effects in Mice. Drug and Alcohol Dependence, 199:106-115. https://doi.org/10.1016/j.drugalcdep.2019.02.020

Spindle, T. R., Cone, E. J., Schlienz, N. J., Mitchell, J. M., Bigelow, G. E., Flegel, R., Hayes, E., & Vandrey, R. (2019). Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid. J Anal Toxicol, 43(4):233-258. https://doi.org/10.1093/jat/bky104

Stasilowicz-Krzemie'n, A., Sip, S., Szulc, P., & Cielecka-Piontek, J. (2023). Determining Antioxidant Activity of Cannabis Leaves Extracts from Different Varieties-Unveiling Nature's Treasure Trove. Antioxidants 2023, 12(7), 1390. https://doi.org/10.3390/antiox12071390

Stasilowicz-Krzemien, A., Nogalska, W., Maszewska, Z., Maleszka, M., Dobron, M., Szary, A., K, A., Zarowski, M., Hojan, K., Lukowicz, M., & Cielecka-Piontek, J. (2024). The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders. International Journal of Molecular Sciences, 25(11), 5749. https://doi.org/10.3390/ijms25115749

Stella, B., Baratta, F., Pepa, C. D., Arpicco, S., Gastaldi, D., & Dosio, F. (2021). Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain. Drugs, Volume 81, pages 1513-1557. https://doi.org/10.1007/s40265-021-01579-x

Stith, S. S., Li, X., Diviant, J. P., Brockelman, F. C., Keeling, K. S., Hall, B., & Vigil, J. M. (2020). CannabisThe effectiveness of inhaled flower for the treatment of agitation/ irritability, anxiety, and common stress. Journal of Cannabis Research, Volume 2, article number 47. https://doi.org/10.1186/s42238-020-00051-z

Suraev, A., McCartney, D., Marshall, N. S., Irwin, C., Vandrey, R., Grunstein, R. R., D'Rozario, A. L., Gordon, C., Bartlett, D., Hoyos, C. M., & McGregor, I. S. (2024). Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial. Psychopharmacology, Volume 241, pages 1815-1825. https://doi.org/10.1007/s00213-024-06595-9

Szaszkiewicz, J., Leigh, S., & Hamilton, T. J. (2021). Robust behavioural effects in response to acute, but not repeated, terpene administration in Zebrafish (Danio rerio). Scientific Reports volume 11, Article number: 19214. https://doi.org/10.1038/s41598-021-98768-1

Szkudlarek, H. J., Desai, S. J., Renard, J., Pereira, B., Norris, C., Jobson, C. E. L., Rajakumar, N., Allman, B. L., & Laviolette, S. R. (2019). Delta-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors. Neuropsychopharmacology volume 44, pages 817-825. https://doi.org/10.1038/s41386-018-0282-7

Talley-Bruns, R. C., Shatkin, M. S., Dhar, Y., & Zelicof, S. B. (2021). The Physiological Effects, Including Risks and Potential Benefits, of Cannabis for Patients Undergoing Elective Orthopedic Procedures. Orthopedics, 44(3):e314-e319. https://doi.org/10.3928/01477447-20210201-03

Tomko, A. M., Whynot, E. G., Ellis, L. D., & Dupré, D. J. (2020). Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis. Cancers, 12(7), 1985. https://doi.org/10.3390/cancers12071985

Urits, I., Borchart, M., Hasegawa, M., Kochanski, J., Orhurhu, V., & Viswanath, O. (2019). An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine. Pain and Therapy, Volume 8, pages 41-51. https://doi.org/10.1007/s40122-019-0114-4

Uziel, A., Gelfand, A., Amsalem, K., Berman, P., Lewitus, G. M., Meiri, D., & Lewitus, D. Y. (2020). Full-Spectrum Cannabis Extract Microdepots Support Controlled Release of Multiple Phytocannabinoids for Extended Therapeutic Effect. ACS Applied Materials & Interfaces Vol 12 Issue 21. https://doi.org/10.1021/acsami.0c04435

Wang, Q., Zhao, X., Jiang, Y., Jin, B., & Wang, L. (2023). Functions of Representative Terpenoids and Their Biosynthesis Mechanisms in Medicinal Plants. Biomolecules, 13(12), 1725. https://doi.org/10.3390/biom13121725

Wardle, M. C., Pabon, E., Webber, H. E., & Wit, H. D. (2022). Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women. Psychopharmacology, Volume 239, pages 1487-1497. https://doi.org/10.1007/s00213-021-06032-1

Wieghorst, A., Roessler, K. K., Hendricks, O., & Andersen, T. E. (2022). The effect of medical cannabis on cognitive functions: a systematic review. Systematic Reviews, Volume 11, article number 210. https://doi.org/10.1186/s13643-022-02073-5

Wolowich, W. R., Greif, R., Theiler, L., & Kleine-Brueggeney, M. (2025). Pharmacokinetic/Pharmacodynamic Modeling of the Acute Heart Rate Effects of Delta-9 Tetrahydrocannabinol and Its Major Metabolites After Intravenous Injection in Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics, Volume 50, pages 229-242. https://doi.org/10.1007/s13318-025-00941-8

Wroblewska-Luczka, P., Cabaj, J., Bargiel, J., & Luszczki, J. J. (2023). Anticancer effect of terpenes: focus on malignant melanoma. Pharmacological Reports, Volume 75, pages 1115-1125. https://doi.org/10.1007/s43440-023-00512-1

Xiao, K. B., Grennell, E., Ngoy, A., George, T. P., Foll, B. L., Hendershot, C. S., & Sloan, M. E. (2023). Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies. Psychopharmacology, Volume 240, pages 1393-1415. https://doi.org/10.1007/s00213-023-06360-4

Zamarripa, C. A., Spindle, T. R., Surujunarain, R., Weerts, E. M., Bansal, S., Unadkat, J. D., Paine, M. F., & Vandrey, R. (2023). Assessment of Orally Administered Delta-9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Delta-9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial. JAMA Network Open, 6(2):e2254752. https://doi.org/10.1001/jamanetworkopen.2022.54752